| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| VEEVVeeva Systems Inc. | 35.99B | 218.95 | 50.68 | 16.2% | 27.93% | 12.22% | 2.97% | 0.01 |
| OPRXOptimizeRx Corporation | 234.87M | 12.60 | -11.45 | 28.81% | 0.03% | 0.03% | 2.03% | 0.28 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 7.22M | 7.75M | 12.13M | 21.21M | 24.6M | 43.31M | 61.29M | 62.45M | 71.52M | 92.13M |
| Revenue Growth % | 0.11% | 0.07% | 0.56% | 0.75% | 0.16% | 0.76% | 0.42% | 0.02% | 0.15% | 0.29% |
| Cost of Goods Sold | 3.62M | 3.41M | 6.17M | 9M | 9.16M | 19.21M | 25.65M | 23.48M | 28.62M | 32.75M |
| COGS % of Revenue | 0.5% | 0.44% | 0.51% | 0.42% | 0.37% | 0.44% | 0.42% | 0.38% | 0.4% | 0.36% |
| Gross Profit | 3.6M | 4.34M | 5.95M | 12.21M | 15.44M | 24.11M | 35.64M | 38.97M | 42.9M | 59.38M |
| Gross Margin % | 0.5% | 0.56% | 0.49% | 0.58% | 0.63% | 0.56% | 0.58% | 0.62% | 0.6% | 0.64% |
| Gross Profit Growth % | 0.1% | 0.21% | 0.37% | 1.05% | 0.26% | 0.56% | 0.48% | 0.09% | 0.1% | 0.38% |
| Operating Expenses | 4.2M | 5.87M | 8.08M | 12.03M | 19.13M | 26.24M | 35.28M | 51.26M | 69.3M | 73.08M |
| OpEx % of Revenue | 0.58% | 0.76% | 0.67% | 0.57% | 0.78% | 0.61% | 0.58% | 0.82% | 0.97% | 0.79% |
| Selling, General & Admin | 3.32M | 5.24M | 6.75M | 10.29M | 14.36M | 19.93M | 33.19M | 49.24M | 58.02M | 61.27M |
| SG&A % of Revenue | 0.46% | 0.68% | 0.56% | 0.49% | 0.58% | 0.46% | 0.54% | 0.79% | 0.81% | 0.67% |
| Research & Development | 290.37K | 398.4K | 1.01M | 675.66K | 1.6M | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 0.04% | 0.05% | 0.08% | 0.03% | 0.07% | - | - | - | - | - |
| Other Operating Expenses | 583.95K | 235.28K | 324.55K | 449K | 3.16M | 6.31M | 2.09M | 2.02M | 11.28M | 11.82M |
| Operating Income | -597.41K | -1.58M | -2.13M | 180.13K | -3.69M | -2.14M | 361.1K | -12.29M | -26.4M | -13.71M |
| Operating Margin % | -0.08% | -0.2% | -0.18% | 0.01% | -0.15% | -0.05% | 0.01% | -0.2% | -0.37% | -0.15% |
| Operating Income Growth % | 0.42% | -1.65% | -0.35% | 1.08% | -21.5% | 0.42% | 1.17% | -35.04% | -1.15% | 0.48% |
| EBITDA | -263.46K | -1.35M | -1.81M | 496.63K | -2.52M | -164.24K | 2.33M | -10.27M | -24M | -9.38M |
| EBITDA Margin % | -0.04% | -0.17% | -0.15% | 0.02% | -0.1% | -0% | 0.04% | -0.16% | -0.34% | -0.1% |
| EBITDA Growth % | 0.65% | -4.11% | -0.34% | 1.28% | -6.07% | 0.93% | 15.17% | -5.41% | -1.34% | 0.61% |
| D&A (Non-Cash Add-back) | 333.95K | 235.28K | 324.55K | 316.5K | 1.18M | 1.97M | 1.97M | 2.02M | 2.4M | 4.33M |
| EBIT | -595.14K | -1.54M | -2.13M | 787.8K | -2.69M | -1.32M | 361.1K | -11.44M | -23.71M | -13.22M |
| Net Interest Income | 2.27K | 42.31K | 25.94K | 46.21K | 288.03K | 68.58K | 16.98K | 852.3K | 738K | -5.83M |
| Interest Income | 2.27K | 42.31K | 25.94K | 46.21K | 288.03K | 68.58K | 16.98K | 852.3K | 2.19M | 329K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.45M | 6.16M |
| Other Income/Expense | 2.27K | 42.31K | 25.94K | 46.21K | 1.45M | -71.81K | 16.98K | 852.3K | 1.24M | -5.68M |
| Pretax Income | -595.14K | -1.54M | -2.1M | 226.34K | -2.24M | -2.21M | 378.08K | -11.44M | -25.16M | -19.39M |
| Pretax Margin % | -0.08% | -0.2% | -0.17% | 0.01% | -0.09% | -0.05% | 0.01% | -0.18% | -0.35% | -0.21% |
| Income Tax | 2.27K | 0 | 0 | 0 | 897.96K | 0 | 0 | 0 | -7.6M | 725K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1.4% | 1% | 1% | 1% | 0.7% | 1.04% |
| Net Income | -595.14K | -1.54M | -2.1M | 226.34K | -3.14M | -2.21M | 378.08K | -11.44M | -17.57M | -20.11M |
| Net Margin % | -0.08% | -0.2% | -0.17% | 0.01% | -0.13% | -0.05% | 0.01% | -0.18% | -0.25% | -0.22% |
| Net Income Growth % | 0.42% | -1.59% | -0.37% | 1.11% | -14.88% | 0.3% | 1.17% | -31.25% | -0.54% | -0.14% |
| Net Income (Continuing) | -595.14K | -1.54M | -2.1M | 226.34K | -3.14M | -2.21M | 378.08K | -11.44M | -17.57M | -20.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07 | -0.16 | -0.21 | 0.02 | -0.23 | -0.15 | 0.02 | -0.64 | -1.03 | -1.10 |
| EPS Growth % | 0.48% | -1.2% | -0.31% | 1.09% | -13.04% | 0.35% | 1.14% | -30.91% | -0.61% | -0.07% |
| EPS (Basic) | -0.07 | -0.16 | -0.21 | 0.02 | -0.23 | -0.15 | 0.02 | -0.64 | -1.03 | -1.10 |
| Diluted Shares Outstanding | 8.19M | 9.9M | 9.82M | 11.86M | 13.39M | 14.83M | 17.69M | 17.78M | 17.12M | 18.29M |
| Basic Shares Outstanding | 8.19M | 9.9M | 9.82M | 11.32M | 13.39M | 14.83M | 17.23M | 17.78M | 17.12M | 18.29M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 11.13M | 10.18M | 8.81M | 15.96M | 27.14M | 32.86M | 115.11M | 98.58M | 54.33M | 53.97M |
| Cash & Short-Term Investments | 8.21M | 7.03M | 5.12M | 8.91M | 18.85M | 10.52M | 84.68M | 74.14M | 13.85M | 13.38M |
| Cash Only | 8.21M | 7.03M | 5.12M | 8.91M | 18.85M | 10.52M | 84.68M | 18.21M | 13.85M | 13.38M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55.93M | 0 | 0 |
| Accounts Receivable | 2.85M | 3.06M | 3.43M | 6.46M | 7.42M | 17.89M | 24.8M | 22.16M | 37.29M | 38.21M |
| Days Sales Outstanding | 143.94 | 144.11 | 103.26 | 111.15 | 110.07 | 150.72 | 147.69 | 129.49 | 190.3 | 151.39 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 608.15K | 473.65K | 404.47K | 387K |
| Total Non-Current Assets | 1.19M | 1.3M | 954.85K | 9.09M | 29.5M | 27.47M | 25.87M | 36.07M | 129.04M | 117.2M |
| Property, Plant & Equipment | 10.24K | 173.65K | 167.31K | 149.33K | 735.88K | 594.83K | 472.64K | 372.77K | 722.3K | 516K |
| Fixed Asset Turnover | 705.21x | 44.64x | 72.49x | 142.01x | 33.43x | 72.82x | 129.68x | 167.53x | 99.02x | 178.54x |
| Goodwill | 0 | 0 | 0 | 3.68M | 14.74M | 14.74M | 14.74M | 22.67M | 78.36M | 70.87M |
| Intangible Assets | 1.17M | 1.12M | 782.5K | 5.26M | 13.94M | 12.12M | 10.65M | 13.02M | 49.4M | 45.52M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.05K | 5.05K | 5.05K | 5.05K | 80.73K | 12.86K | 12.86K | 5.05K | 568.05K | 296K |
| Total Assets | 12.31M | 11.48M | 9.76M | 25.05M | 56.64M | 60.33M | 140.99M | 134.65M | 183.37M | 171.17M |
| Asset Turnover | 0.59x | 0.68x | 1.24x | 0.85x | 0.43x | 0.72x | 0.43x | 0.46x | 0.39x | 0.54x |
| Asset Growth % | 0.75% | -0.07% | -0.15% | 1.57% | 1.26% | 0.07% | 1.34% | -0.04% | 0.36% | -0.07% |
| Total Current Liabilities | 3.37M | 3.67M | 3.54M | 4.23M | 6.11M | 10.03M | 9.37M | 8.4M | 17.88M | 18.65M |
| Accounts Payable | 3.14M | 369.21K | 457.29K | 411.01K | 493K | 618.25K | 606.81K | 1.55M | 2.23M | 2.16M |
| Days Payables Outstanding | 316.19 | 39.5 | 27.03 | 16.67 | 19.65 | 11.75 | 8.63 | 24.09 | 28.4 | 24.03 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | 2M |
| Deferred Revenue (Current) | 227K | 386.58K | 507.16K | 610.63K | 580.01K | 285.8K | 1000K | 164.31K | 171.84K | 473K |
| Other Current Liabilities | 0 | 0 | 0 | 1.91M | 0 | 0 | 0 | 0 | 5.55M | 0 |
| Current Ratio | 3.30x | 2.78x | 2.49x | 3.77x | 4.44x | 3.28x | 12.29x | 11.74x | 3.04x | 2.89x |
| Quick Ratio | 3.30x | 2.78x | 2.49x | 3.77x | 4.44x | 3.28x | 12.29x | 11.74x | 3.04x | 2.89x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 2.91M | 2.58M | 2.37M | 5.67M | 325.53K | 236.73K | 144.53K | 38.94M | 35.52M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.23M | 30.82M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 448.75K | 325.53K | 236.73K | 144.53K | 371.44K | 209K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.34M | 4.49M |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2.37M | 5.22M | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.37M | 3.67M | 3.54M | 6.6M | 11.78M | 10.35M | 9.61M | 8.54M | 56.82M | 54.17M |
| Total Debt | 0 | 0 | 0 | 0 | 564.18K | 448.75K | 327.71K | 234.43K | 36.82M | 33.19M |
| Net Debt | -8.21M | -7.03M | -5.12M | -8.91M | -18.29M | -10.07M | -84.35M | -17.97M | 22.97M | 19.81M |
| Debt / Equity | - | - | - | - | 0.01x | 0.01x | 0.00x | 0.00x | 0.29x | 0.28x |
| Debt / EBITDA | - | - | - | - | - | - | 0.14x | - | - | - |
| Net Debt / EBITDA | - | - | - | -17.95x | - | - | -36.26x | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | -18.16x | -2.23x |
| Total Equity | 8.94M | 7.81M | 6.22M | 18.46M | 44.86M | 49.97M | 131.38M | 126.11M | 126.55M | 117M |
| Equity Growth % | 0.94% | -0.13% | -0.2% | 1.97% | 1.43% | 0.11% | 1.63% | -0.04% | 0% | -0.08% |
| Book Value per Share | 1.09 | 0.79 | 0.63 | 1.56 | 3.35 | 3.37 | 7.43 | 7.09 | 7.39 | 6.40 |
| Total Shareholders' Equity | 8.94M | 7.81M | 6.22M | 18.46M | 44.86M | 49.97M | 131.38M | 126.11M | 126.55M | 117M |
| Common Stock | 29.03K | 29.72K | 29.32K | 12.04K | 14.6K | 15.22K | 17.86K | 18.29K | 19.9K | 20K |
| Retained Earnings | -26.72M | -28.26M | -30.36M | -30.28M | -33.42M | -35.63M | -35.25M | -46.69M | -64.26M | -84.37M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.21K | -1.74K | -2K |
| Accumulated OCI | -22.41K | -25.69K | -74.28K | -104.7K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 515.11K | -465.96K | -1.48M | 792.55K | -1.66M | -6.31M | 726.04K | 10.65M | -7.24M | 4.89M |
| Operating CF Margin % | 0.07% | -0.06% | -0.12% | 0.04% | -0.07% | -0.15% | 0.01% | 0.17% | -0.1% | 0.05% |
| Operating CF Growth % | 10.14% | -1.9% | -2.18% | 1.54% | -3.1% | -2.8% | 1.12% | 13.67% | -1.68% | 1.68% |
| Net Income | -595.14K | -1.54M | -2.1M | 226.34K | -3.14M | -2.21M | 378.08K | -11.44M | -17.57M | -20.11M |
| Depreciation & Amortization | 333.95K | 235.28K | 324.55K | 316.5K | 1.28M | 2.08M | 1.97M | 2.02M | 2.4M | 4.33M |
| Stock-Based Compensation | 327.75K | 175.18K | 87.38K | 1.86M | 2.26M | 3.17M | 5.49M | 15.75M | 13.72M | 11.47M |
| Deferred Taxes | 31.73K | 0 | 65.74K | 2.4K | -897.96K | 200K | 0 | 0 | 0 | 1.45M |
| Other Non-Cash Items | 253.36K | 384.13K | 815.01K | 656.93K | 635K | 140.39K | 80K | 363.51K | 9.76M | 6.83M |
| Working Capital Changes | 163.46K | 278.65K | -668.48K | -2.27M | -1.8M | -9.69M | -7.19M | 3.96M | -15.55M | 921K |
| Change in Receivables | -747.07K | -212.95K | -370.49K | -2.79M | -548.83K | -10.67M | -6.99M | 2.28M | -8.71M | -2.17M |
| Change in Inventory | -61.01K | 271.09K | 491.07K | -93.22K | -882.48K | -2.21M | 0 | 0 | 0 | 0 |
| Change in Payables | 864.67K | 60.93K | -909.64K | 647.49K | -336.43K | 3.48M | -603.09K | 555.39K | 195K | -72K |
| Cash from Investing | -100.96K | -349.54K | -42.24K | -5.69M | -10.58M | -124.72K | -486K | -58.18M | -25.34M | -450K |
| Capital Expenditures | -100.96K | -349.54K | -42.24K | -91.01K | -1.59M | -68.04K | -100.32K | -81K | -87K | -112K |
| CapEx % of Revenue | 0.01% | 0.05% | 0% | 0% | 0.06% | 0% | 0% | 0% | 0% | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -98.92K | -171.1K | 0 | -56.65K | 0 | -56.68K | -385.68K | -163.56K | -774K | -338K |
| Cash from Financing | 4.35M | -357.42K | -390K | 8.69M | 22.18M | -1.9M | 73.92M | -18.95M | 28.22M | -4.91M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 0 | 521.26K | 877.7K | -4.39M | 3.25M | 1.07M | -278K | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | 414.15K | -815.5K | -1.52M | 701.54K | -3.25M | -6.44M | 240.04K | 10.41M | -8.11M | 4.78M |
| FCF Margin % | 0.06% | -0.11% | -0.13% | 0.03% | -0.13% | -0.15% | 0% | 0.17% | -0.11% | 0.05% |
| FCF Growth % | 1.89% | -2.97% | -0.87% | 1.46% | -5.63% | -0.98% | 1.04% | 42.37% | -1.78% | 1.59% |
| FCF per Share | 0.05 | -0.08 | -0.16 | 0.06 | -0.24 | -0.43 | 0.01 | 0.59 | -0.47 | 0.26 |
| FCF Conversion (FCF/Net Income) | -0.87x | 0.30x | 0.70x | 3.50x | 0.53x | 2.86x | 1.92x | -0.93x | 0.41x | -0.24x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.21M | 6.2M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48K | 161K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -8.78% | -18.37% | -29.99% | 1.83% | -9.93% | -4.65% | 0.42% | -8.88% | -13.9% | -16.51% |
| Return on Invested Capital (ROIC) | -47.21% | -156.85% | -170.35% | 2.54% | -15.34% | -4.82% | 0.62% | -11.88% | -15.37% | -7.18% |
| Gross Margin | 49.84% | 55.99% | 49.09% | 57.56% | 62.77% | 55.65% | 58.14% | 62.4% | 59.98% | 64.45% |
| Net Margin | -8.24% | -19.86% | -17.35% | 1.07% | -12.78% | -5.1% | 0.62% | -18.32% | -24.56% | -21.83% |
| Debt / Equity | - | - | - | - | 0.01x | 0.01x | 0.00x | 0.00x | 0.29x | 0.28x |
| Interest Coverage | - | - | - | - | - | - | - | - | -18.16x | -2.23x |
| FCF Conversion | -0.87x | 0.30x | 0.70x | 3.50x | 0.53x | 2.86x | 1.92x | -0.93x | 0.41x | -0.24x |
| Revenue Growth | 11.04% | 7.35% | 56.45% | 74.86% | 15.99% | 76.08% | 41.51% | 1.89% | 14.53% | 28.81% |
OptimizeRx Corporation (OPRX) reported $109.5M in revenue for fiscal year 2024. This represents a 9752% increase from $1.1M in 2011.
OptimizeRx Corporation (OPRX) grew revenue by 28.8% over the past year. This is strong growth.
Yes, OptimizeRx Corporation (OPRX) is profitable, generating $0.0M in net income for fiscal year 2024 (-21.8% net margin).
OptimizeRx Corporation (OPRX) has a return on equity (ROE) of -16.5%. Negative ROE indicates the company is unprofitable.
OptimizeRx Corporation (OPRX) generated $11.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.